SNDL (SNDL) shares gained nearly 12% on Wednesday. Dec. 16 following reports that President Donald Trump could reclassify cannabis as a “Schedule III” drug by the end of this week. The U.S. government is considering a policy shift that would offer some seniors access to cannabis products under Medicare coverage as well, the reports added. More News from Barchart SNDL stock has been a volatile investment this year. Despite a sharp rally on Tuesday, it’s down more than 25% versus its year-to-date high in ...

行业政策动态 - 自8月以来 大麻行业势头增强 政策转向积极方向 [1] - 政策积极转变得到前总统特朗普关于重新安排大麻分级和支持医用大麻的言论支持 [1] 作者背景与方法 - 作者曾担任一家专注于中小型市值公司的财经媒体执行主编 利用经验发掘被低估公司的投资机会 [1] - 作者结合金融市场和机构的学术背景 对财务报表 市场趋势以及可能影响特定公司或行业的即将发生的事件进行深入研究分析 [1]